As part of our commitment to research and transparency, we publish peer-reviewed scientific studies in academic journals, white papers, and blog posts regarding the clinical or financial/cost savings results of our comprehensive, holistic treatment. 

Recently, our data science and research teams looked at our program’s 2024 data regarding:

1. How many people out of the ones that start Meru Health’s therapy program receive at least a 1-point improvement in either PHQ-9 or GAD-7 measures (standardized measures for depression and anxiety symptoms)?

    

2. What percentage (%) of Meru Health’s therapy program completers reach at least 50% symptom reduction with PHQ-9 or GAD-7?

    

3. What percentage (%) of Meru Health’s therapy program completers reach full symptom remission (described as PHQ-9 5 or under or GAD-7 4 or under)?

    

We’re excited to share these results. 

How many people out of the ones that start Meru Health’s therapy program receive at least a 1-point improvement in either PHQ-9 or GAD-7 measures?

Of 17,316 people who started our treatment program at the latest in March 2024 and either became a “completer” or a “dropout,” 15,999 (92%) received at least a 1-point improvement in either PHQ-9 or GAD-7.

The teams also examined the percentage of completers who received at least a 1-point improvement in either PHQ-9 or GAD-7.

Of 13,892 people who started our treatment program as of March 2024 and became a “completer,” 13,045 (94%) received at least a 1-point improvement in either PHQ-9 or GAD-7.

What percentage (%) of Meru Health’s therapy program completers reach at least 50% symptom reduction with PHQ-9 or GAD-7? 

In March 2024, 78% of people who completed our treatment program achieved at least a 50% reduction in either PHQ-9 or GAD-7 symptoms.

What percentage (%) of Meru Health’s therapy program completers reach full symptom remission (described as PHQ-9 5 or under or GAD-7 4 or under)?

In March 2024, of people who completed our treatment program, 57% reached full symptom remission with either PHQ-9 or GAD-7.

Meru Health results: Our treatment makes a difference

With 92% of participants showing at least a 1-point improvement in PHQ-9 or GAD-7 measures and 78% of completers achieving a 50% symptom reduction, the impact of our holistic treatment program is evident. Notably, 57% of completers reached full symptom remission, highlighting our program’s potential for significant mental health improvements.

Learn more about how our therapist-supported digital mental health intervention is reducing depression symptoms.

Methods

The PHQ-9 and GAD-7 data summarized here is collected from Meru Health patients who use Meru Health’s clinical mental health services on a bi-weekly basis. This data is collected as part of Meru Health’s care process for all patients and then summarized by Meru Health’s data science and research teams in an aggregate format as statistical data that is unidentifiable and respects patient privacy. The data presented here has not been through a peer-review process and has not been published in a medical journal. This kind of de-identified data is exempt from IRB approvals and can be published under 45 CFR 46.104(d)(4).

We remain committed to transparency and ongoing research to deliver high-quality mental health care.